PERCEPTIVE ADVISORS LLC 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 1,800,000 3.600% | -350,641 (-16.30%) | Filing |
| 2022-02-14 3:46 pm Unchanged | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 2,150,641 6.200% | 0 (Unchanged) | Filing |
| 2021-02-16 3:30 pm Unchanged | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 2,150,641 7.000% | 0 (Unchanged) | Filing |